课题基金 / 基金详情

Molecular and cellular mechanisms of heterotopic ossification

Molecular and cellular mechanisms of heterotopic ossification
异位骨化的分子和细胞机制
批准号:
10757487
负责人:
PAUL B YU
金额:
$29.24万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2024-06-30
关键词:
ACVR1 geneActivin ReceptorActivinsAddressAllelesAnimal ModelAutoimmune DiseasesBiological AssayBiologyBiomechanicsBirthBlood VesselsBone Morphogenetic ProteinsCRISPR/Cas technologyCardiovascular DiseasesCell Differentiation processCell LineCell modelCellsCellular biologyCharacteristicsChemicalsCollaborationsComplexConnective TissueDegenerative DisorderDiseaseEngineeringExhibitsFamilyFasciaFundingGeneticGenetic ModelsGoalsHematologyHeterotopic OssificationHomeostasisHumanHybridsImmobilizationImmunologyIn VitroIndividualInfiltrationInflammationInjuryInterventionIntramuscularJointsKnock-inKnock-in MouseKnowledgeLeadLigamentsLigandsMalignant NeoplasmsMapsMediatingMetabolic DiseasesMetabolic stressMolecularMorbidity - disease rateMuscleMusculoskeletal DevelopmentMusculoskeletal DiseasesMutationNational Center for Advancing Translational SciencesOsteogenesisPainPathologicPatientsPhosphotransferasesPhysiologic OssificationPopulationProcessProphylactic treatmentReceptor SignalingResistanceRoleSignal PathwaySignal TransductionSignaling ProteinSkeletal MuscleSpecific qualifier valueStressSyndromeSystemTechniquesTechnologyTendon structureTestingTissuesTransforming Growth Factor betaTraumaTraumatic injuryType I Activin ReceptorsVascular calcificationWorkactivin Aanalytical toolbonebone morphogenetic protein receptor type Ibone morphogenetic protein receptorscancer cellcell typecombinatorialdrug developmenteffective therapyefficacy evaluationemerging adultfield studyhigh throughput screeninginduced pluripotent stem cellinhibitorinjury and repairinnovationinsightinterstitialiron metabolismkinase inhibitormouse modelmutantneglectneutralizing antibodynovelosteogenicpharmacologicpreventprogenitorprogramsprogressive myositis ossificansreceptorrepairedresistance mutationscaffoldsenescenceskeletal abnormalitysoft tissuestem cellstissue regenerationtooltool developmenttranslatable strategy

项目摘要

项目成果

PAUL B YU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Heterotopic ossification (HO), the formation of ectopic endochondral bone in skeletal muscle and soft tissues, is a significant cause of morbidity from joint immobility and pain. The precise mechanisms responsible for HO are not known; however, its association with trauma, inflammation and biomechanical stress suggests a process of disordered injury repair and homeostasis. We have explored the underlying mechanisms of a monogenic cause of HO, fibrodysplasia ossificans progressiva (FOP), caused by activating mutations of the bone morphogenetic protein (BMP) type I receptor ALK2, whereas trauma-induced HO appears to be regulated by ALK2, ALK3 and potentially ALK6. FOP and acquired forms of HO share a common mechanism of inappropriate BMP signaling, but the manner by which BMP signals are interpreted to regulate ossification versus tissue regeneration remain incompletely understood. Significant gaps exist in how combinatorial BMP/TGFb signal transduction specifies diverse functions and cell fates in multipotent lineages. To address these mechanistic gaps, an innovative chemical biology platform has been devised using human- derived MSC that have been edited by CRISPR/Cas9 techniques, combined with a novel BMP/TGF-b pharmacologic probe identified from an active NCATS-TRND collaboration. This platform will permit the unequivocal mapping of individual ligand and receptor signaling, and the downstream impact on MSC plasticity in a non-overexpressed human cell system. This assay provides a platform for a high throughput screen to be performed with collaborators at NCATS-TRND to identify mechanistically novel modulators of ALK2, ALK3 and ALK6. Finally, insights and candidate molecules identified from these studies will be validated in a conditional knock-in mouse model of FOP, and in an authentic mouse model of trauma- and inflammation-induced HO. These studies will provide critical tools and insights into how the BMP signaling pathway contributes to pathologic tissue remodeling in musculoskeletal and degenerative disease, as well as in a broader set of conditions in which HO is associated with senescence, inflammation, and metabolic stress. New assay technologies, tool compounds, and translatable insights will be produced as a result of this work that will be relevant to many other disease-oriented fields of study.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
体外药物代谢研究在治疗进行性骨化性纤维发育不良 (FOP) 的化学结构优化中的应用。
DOI: 10.3389/fphar.2019.00234
发表时间: 2019
期刊: Frontiers in pharmacology
影响因子: 5.6
作者: [Padilha,EliasC, Wang,Jianyao, Kerns,Ed, Lee,Arthur, Huang,Wenwei, Jiang,Jian-Kang, McKew,John, Mutlib,Abdul, Peccinini,RosangelaG, Yu,PaulB, Sanderson,Philip, Xu,Xin]
通讯作者: Xu,Xin
DOI: 10.1016/j.bmcl.2018.09.006
发表时间: 2018-11-01
期刊: Bioorganic & medicinal chemistry letters
影响因子: 2.7
作者: [Jiang JK, Huang X, Shamim K, Patel PR, Lee A, Wang AQ, Nguyen K, Tawa G, Cuny GD, Yu PB, Zheng W, Xu X, Sanderson P, Huang W]
通讯作者: Huang W
DOI: 10.1172/jci153792
发表时间: 2022-06-15
期刊: JOURNAL OF CLINICAL INVESTIGATION
影响因子: 15.9
作者: [Aykul, Senem, Huang, Lily, Wang, Lili, Das, Nanditha M., Reisman, Sandra, Ray, Yonaton, Zhang, Qian, Rothman, Nyanza, Nannuru, Kalyan C., Kamat, Vishal, Brydges, Susannah, Troncone, Luca, Johnsen, Laura, Yu, Paul B., Fazio, Sergio, Lees-Shepard, John, Schutz, Kevin, Murphy, Andrew J., Economides, Aris N., Idone, Vincent, Hatsell, Sarah J.]
通讯作者: Hatsell, Sarah J.
DOI: 10.1016/j.scr.2021.102424
发表时间: 2021-07
期刊: STEM CELL RESEARCH
影响因子: 1.2
作者: [Huang, Xiuli, Roeder, Amanda, Li, Rong, Beers, Jeanette, Liu, Chengyu, Zou, Jizhong, Yu, Paul B., Zheng, Wei]
通讯作者: Zheng, Wei
18
    Context-specific angiogenic signaling in the pulmonary vasculature
    • 批准号:
      10280040
    • 项目类别:
    • 资助金额:
      $62.56万
    • 财政年份:
      2021
    • 负责人:
      PAUL B YU
    • 依托单位:
    Context-specific angiogenic signaling in the pulmonary vasculature
    • 批准号:
      10770822
    • 项目类别:
    • 资助金额:
      $58.96万
    • 财政年份:
      2021
    • 负责人:
      PAUL B YU
    • 依托单位:
    Context-specific angiogenic signaling in the pulmonary vasculature
    • 批准号:
      10450846
    • 项目类别:
    • 资助金额:
      $60.44万
    • 财政年份:
      2021
    • 负责人:
      PAUL B YU
    • 依托单位:
    HLS- Cyclic CAR peptide: a targeted therapy for pulmonary hypertension
    • 批准号:
      9347715
    • 项目类别:
    • 资助金额:
      $30.24万
    • 财政年份:
      2017
    • 负责人:
      PAUL B YU
    • 依托单位:
    海外基金